Salient Surgical Technologies Settles Bovie Medical Patent Infringement Lawsuit

Loading...
Loading...

Salient Surgical Technologies, Inc., a privately held medical technology company that develops and markets advanced energy devices for use in surgical procedures, announced today a settlement in the Company's patent infringement lawsuit against Bovie® Medical BVX.

Under the terms of the settlement, Bovie will immediately exit the monopolar and bipolar saline-enhanced RF device business (including Bovie's SEER™ and BOSS™) worldwide, until February 2015. In addition, Bovie acknowledges the validity and enforceability of Medtronic's patent – to which Salient has exclusive legal rights – in the U.S. and Europe. In exchange, Medtronic will make a one-time payment to Bovie of $750,000.

Posted In: NewsLegalHealth CareHealth Care Equipment
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...